MedTrace Logo

Comparative Study of 99mTc-FAPI SPECT/CT and 68Ga-FAPI PET/CT

NCT05444686 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2022-07-06

No results posted yet for this study

Summary

The purpose of this study is to compare the similarities and differences of 99mTc-FAPI quantitative SPECT/CT and 68Ga-FAPI PET/CT in the diagnosis and staging of gastrointestinal tumors, and clinical diagnosis and economic value of 99mTc-FAPI quantitative SPECT/CT for the gastrointestinal tumors.

Conditions

  • 99mTc-FAPI-positive Gastrointestinal Tumor

Interventions

DIAGNOSTIC_TEST

99mTc-FAPI

inject the tracer to subjects and perform SPECT/CT scans

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2024-06-30
Completion
2024-07-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05444686 on ClinicalTrials.gov